ADMA Biologics Inc - Common Stock - Nakit Akışı (NASDAQ:ADMA) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -102 M-112.37 M-59.51 M8.8 M118.67 M50.4 M 128.32 M Yatırım faaliyetlerinden elde edilen nakit -12.72 M-13.51 M-13.91 M-4.98 M-8.57 M-21.89 M -14.77 M Finansman faaliyetlerinden elde edilen nakit 143.9 M121.05 M108.85 M-38.99 M-58.3 M-44.02 M -47.02 M Serbest nakit akışı -102 M-112.37 M-59.51 M8.8 M118.67 M27.5 M 107.55 M

Haberler

ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

New Strong Sell Stocks for May 26th

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

Adma Biologics yönetim kurulu üyesi Jerrold Grossman 100.125 dolar değerinde hisse aldı

New Strong Sell Stocks for May 14th

ADMA Biologics gerçeğe uygun değer çağrısı dalgalanmaya rağmen %50 kazandırdı

ADMA Biologics 1Ç 2026 sonuçları beklentilerin altında kaldı

New Strong Sell Stocks for May 11th

ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down